Sanghee Kim1, Youngsoon Byun2. 1. Neuroscience Center, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Republic of Korea even07@ewhain.net. 2. Division of Nursing Science, College of Health Science, Ewha Womans University, Seoul, Republic of Korea.
Abstract
PURPOSE: We aimed to compare the changes in renal function indicators as a function of hydration volume in patients treated with acyclovir for suspected herpes simplex virus (HSV) infection. METHOD: We obtained data from 216 acyclovir-treated patients hospitalized between 2007 and 2012 for suspected HSV infection. Intravenous hydration volume and renal function indicators (serum creatinine [sCr], blood urea nitrogen [BUN], glutamate oxaloacetate transferase, glutamate pyruvate transferase, and uric acid levels; estimated glomerular filtration rate [eGFR]; and urine pH) were compared among the patients. The indicators were assessed before acyclovir infusion and after 3 days of acyclovir infusion. RESULTS: Before acyclovir infusion, all the indicators were within normal ranges in all groups (hydration volume lower than 2 L/day, higher than 2 L/day, and without hydration). After acyclovir infusion for 3 days, the groups without hydration and with a volume lower than 2 L/day showed increased sCr (2.22 ± 0.51 and 1.70 ± 0.35 mg/dl, respectively), BUN levels (28.33 ± 0.57 and 22.14 ± 7.95 mg/dl, respectively), and glutamate oxaloacetate transferase (48.00 ± 2.65 IU/L, without hydration) and eGFRs lower than the normal range (53.03 ± 3.05 and 59.66 ± 10.25 ml/min, respectively; p < .001 for all parameters). The renal function indicators were within normal limits in the group with a hydration volume higher than 2 L/day. CONCLUSIONS: Renal function indicators in acyclovir-treated patients varied according to hydration volume. Health care providers should consider whether the hydration volume in each patient receiving intravenous acyclovir is sufficient for preventing nephropathy.
PURPOSE: We aimed to compare the changes in renal function indicators as a function of hydration volume in patients treated with acyclovir for suspected herpes simplex virus (HSV) infection. METHOD: We obtained data from 216 acyclovir-treated patients hospitalized between 2007 and 2012 for suspected HSV infection. Intravenous hydration volume and renal function indicators (serum creatinine [sCr], blood ureanitrogen [BUN], glutamate oxaloacetate transferase, glutamate pyruvate transferase, and uric acid levels; estimated glomerular filtration rate [eGFR]; and urine pH) were compared among the patients. The indicators were assessed before acyclovir infusion and after 3 days of acyclovir infusion. RESULTS: Before acyclovir infusion, all the indicators were within normal ranges in all groups (hydration volume lower than 2 L/day, higher than 2 L/day, and without hydration). After acyclovir infusion for 3 days, the groups without hydration and with a volume lower than 2 L/day showed increased sCr (2.22 ± 0.51 and 1.70 ± 0.35 mg/dl, respectively), BUN levels (28.33 ± 0.57 and 22.14 ± 7.95 mg/dl, respectively), and glutamate oxaloacetate transferase (48.00 ± 2.65 IU/L, without hydration) and eGFRs lower than the normal range (53.03 ± 3.05 and 59.66 ± 10.25 ml/min, respectively; p < .001 for all parameters). The renal function indicators were within normal limits in the group with a hydration volume higher than 2 L/day. CONCLUSIONS: Renal function indicators in acyclovir-treated patients varied according to hydration volume. Health care providers should consider whether the hydration volume in each patient receiving intravenous acyclovir is sufficient for preventing nephropathy.
Authors: Petya Bogdanova-Mihaylova; David Burke; John P O'Dwyer; David Bradley; Jennifer A Williams; Simon J Cronin; Shane Smyth; Raymond P Murphy; Sinead M Murphy; Catherine Wall; Dominick J H McCabe Journal: Ir J Med Sci Date: 2018-01-06 Impact factor: 1.568
Authors: Kevin J Downes; Craig L K Boge; Elande Baro; Gerold T Wharton; Kellie M Liston; Brittany L Haltzman; Hannah M Emerson; Edwin Doe; Rosanna Fulchiero; Van Tran; Lilly Yen; Phuong Lieu; Sara L Van Driest; Alison G Grisso; Ida T Aka; Jennifer Hale; Jessica Gillon; Julie S Pingel; Susan E Coffin; Ann W McMahon Journal: J Pediatr Date: 2020-02-06 Impact factor: 4.406
Authors: Abdullah M Al-Alawi; Juhaina Salim Al-Maqbali; Maria Al-Adawi; Anan Al-Jabri; Henrik Falhammar Journal: Saudi Pharm J Date: 2022-03-26 Impact factor: 4.562